Matthieu Vallin

BioOrbit is space manufacturing company developing hardware for the large-scale crystallisation of protein drugs. Our grand aim is to develop a pharmaceuticals factory in space within the next 10 years. We are dreaming big and making it happen. In-orbit demo early 2025. Accelerators (most recent first) - Airbus Accelerator Cohort 1 - Seraphim Space Accelerator Mission 12 - ESA BSGN Life Sciences - ESA BIC UK - UK Space Agency LEO Accelerator If you are interested in learning more, please reach out to business@bioorbit.space

Apheris enables governed, private, and secure access to data for ML and analytics. As model architectures become increasingly commoditized, data becomes an organization’s key differentiator. However, businesses need to safeguard their data assets and IP while leveraging it for ML. Our product, the Apheris Compute Gateway, ensures only approved computations can be launched on that data. It also enables federation across organizational boundaries, allowing ML-powered insights with no need to centralize data, while ensuring compliance with data privacy, security, and governance obligations. Founded in 2019, Apheris is backed by top investors and tech industry innovators, including Octopus Ventures, Heal Capital, LocalGlobe, another.vc, MuleSoft founder Ross Mason (Dig Ventures), and Twitter board chairman and former CFO of Google, Patrick Pichette.

Make care flows work harder than care teams with Awell Awell is a low-code platform used by clinical and product teams to design clinical workflows and integrate them into their tech stack. With Awell, care organizations automate routine clinical tasks, synchronize data between systems and drive seamless coordination between care teams and patients. Awell’s customers have improved the lives of hundreds of thousands of patients across a wide array of medical conditions. They achieved results such as a 50% increase in care team capacity, a 40% reduction in length of stay, and a 25% reduction in emergency room admissions.

Tympa is a team of doctors and technology experts united by a mission to help the world achieve better ear and hearing health. We set out to create the world’s first all-in-one ear and hearing healthcare assessment platform, designed to deliver and accelerate both diagnosis and treatment within a single 30-minute appointment. The Tympa Platform, coupled with our Tympa Academy training program, enables practitioners to provide care to everyone who needs it, and sets our partners up for excellence and confidence. Our network is always growing. See if Tympa is right for you ➡️ https://tympahealth.io/Tympa-Home-LI

CoMind is revolutionising brain healthcare with its non-invasive technology, redefining how the brain is measured and treated to optimise patient outcomes across the care continuum. Based in London, CoMind designs and manufactures a groundbreaking approach to brain monitoring, which provides a multidimensional view of brain activity using light. It enhances patient safety, improves healthcare economics, and improves clinical outcomes. Their AI-powered platform, CoVision, delivers predictive insights, enabling clinicians to anticipate complications. With a focus on precision medicine, CoMind is setting new standards in brain health, from intensive care to surgeries to the emergency room​. CoMind is backed by leading investors such as Octopus Ventures, LocalGlobe, Angelini Ventures and Crane Venture Partners, alongside several high profile angel investors. We are currently hiring for multiple roles: https://comind.jobs.personio.com/.

Talking with patients is the basis of all healthcare. Ufonia combines AI and clinical evidence to automate routine clinical conversations. Our technology makes care more convenient, reliable and consistent for patients; increases hospitals’ capacity; and allows clinical professionals to spend more time meeting patients’ needs.

Mental Fitness: The capacity to engage with life’s emotional and cognitive challenges proactively, enthusiastically, and with strength. Not as signs of weakness but as opportunities for growth. We’re building the tools to help health systems move forward. We’re empowering individuals with better health to face life’s challenges. And we’re building mental healthcare that is more personal, preventative, and powerful.

BioOrbit is space manufacturing company developing hardware for the large-scale crystallisation of protein drugs. Our grand aim is to develop a pharmaceuticals factory in space within the next 10 years. We are dreaming big and making it happen. In-orbit demo early 2025. Accelerators (most recent first) - Airbus Accelerator Cohort 1 - Seraphim Space Accelerator Mission 12 - ESA BSGN Life Sciences - ESA BIC UK - UK Space Agency LEO Accelerator If you are interested in learning more, please reach out to business@bioorbit.space

At Breega, we back world-class founders for the future. We’re not simple investors - we’re entrepreneurs who’ve built, scaled, and learned what it really takes to grow. Our forte is not just writing checks: it’s rolling up our sleeves - with our Scaling Squad, our portfolio companies get hands-on expertise in hiring, sales, marketing and strategy so they don’t just expand, they dominate. We partner with outliers rewriting the rules of Digital, Climate, and Deep Tech from pre-Seed to Series A+ across Europe and Africa. Since 2015, we’ve grown to €700M AUM, with main offices in London and Paris and deep roots in the most thriving tech hubs across both continents, as well as a portfolio of 110+ bold startups—Exotec, Alice & Bob, Moneybox, 011H, etc—each pushing the boundaries of what’s possible. Certified BCorp

Apheris enables governed, private, and secure access to data for ML and analytics. As model architectures become increasingly commoditized, data becomes an organization’s key differentiator. However, businesses need to safeguard their data assets and IP while leveraging it for ML. Our product, the Apheris Compute Gateway, ensures only approved computations can be launched on that data. It also enables federation across organizational boundaries, allowing ML-powered insights with no need to centralize data, while ensuring compliance with data privacy, security, and governance obligations. Founded in 2019, Apheris is backed by top investors and tech industry innovators, including Octopus Ventures, Heal Capital, LocalGlobe, another.vc, MuleSoft founder Ross Mason (Dig Ventures), and Twitter board chairman and former CFO of Google, Patrick Pichette.

Make care flows work harder than care teams with Awell Awell is a low-code platform used by clinical and product teams to design clinical workflows and integrate them into their tech stack. With Awell, care organizations automate routine clinical tasks, synchronize data between systems and drive seamless coordination between care teams and patients. Awell’s customers have improved the lives of hundreds of thousands of patients across a wide array of medical conditions. They achieved results such as a 50% increase in care team capacity, a 40% reduction in length of stay, and a 25% reduction in emergency room admissions.

Tympa is a team of doctors and technology experts united by a mission to help the world achieve better ear and hearing health. We set out to create the world’s first all-in-one ear and hearing healthcare assessment platform, designed to deliver and accelerate both diagnosis and treatment within a single 30-minute appointment. The Tympa Platform, coupled with our Tympa Academy training program, enables practitioners to provide care to everyone who needs it, and sets our partners up for excellence and confidence. Our network is always growing. See if Tympa is right for you ➡️ https://tympahealth.io/Tympa-Home-LI